title: Crohn’s disease: towards improving postsurgical outcomes.
authors.forename: Trevor J
authors.initials: TJ
authors.lastname: Lockett
authors.forename: Michael A
authors.initials: MA
authors.lastname: Kamm
authors.forename: Peter
authors.initials: P
authors.lastname: De Cruz
authors.forename: Carl D
authors.initials: CD
authors.lastname: Kirkwood
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D003113:Colonoscopy; D003424:Crohn Disease / Q000382:microbiology / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007413:Intestinal Mucosa / Q000382:microbiology / Q000473:pathology; D017063:Outcome Assessment, Health Care; D011182:Postoperative Care; D011183:Postoperative Complications / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D012086:Reoperation; D012307:Risk Factors; D055502:Secondary Prevention; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab